These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20979592)

  • 21. Free thiol groups in von Willebrand factor (VWF) are required for its full function under physiological flow conditions.
    Solecka BA; Weise C; Fuchs B; Kannicht C
    Thromb Res; 2016 Jan; 137():202-210. PubMed ID: 26581637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The alpha1 helix-beta13 strand spanning Leu214 to Val229 of platelet glycoprotein Ibalpha facilitates the interaction with von Willebrand factor: evidence from characterization of the epitope of monoclonal antibody AP1.
    Peng Y; Berndt MC; Cruz MA; López JA
    Blood; 2004 Dec; 104(13):3971-8. PubMed ID: 15319289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a myeloma patient with a life-threatening hemorrhagic diathesis: presence of a lambda dimer protein inhibiting shear-induced platelet aggregation by binding to the A1 domain of von Willebrand factor.
    Shinagawa A; Kojima H; Berndt MC; Kaneko S; Suzukawa K; Hasegawa Y; Shigeta O; Nagasawa T
    Thromb Haemost; 2005 May; 93(5):889-96. PubMed ID: 15886805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
    Miura S; Li CQ; Cao Z; Wang H; Wardell MR; Sadler JE
    J Biol Chem; 2000 Mar; 275(11):7539-46. PubMed ID: 10713059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond.
    Nakayama T; Matsushita T; Dong Z; Sadler JE; Jorieux S; Mazurier C; Meyer D; Kojima T; Saito H
    J Biol Chem; 2002 Jun; 277(24):22063-72. PubMed ID: 11943773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thioredoxin Inhibitors Attenuate Platelet Function and Thrombus Formation.
    Metcalfe C; Ramasubramoni A; Pula G; Harper MT; Mundell SJ; Coxon CH
    PLoS One; 2016; 11(10):e0163006. PubMed ID: 27716777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
    Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
    J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
    Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
    Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shear-dependent functions of the interaction between soluble von Willebrand factor and platelet glycoprotein Ib in mural thrombus formation on a collagen surface.
    Sugimoto M; Tsuji S; Kuwahara M; Matsui H; Miyata S; Fujimura Y; Yoshioka A
    Int J Hematol; 1999 Jan; 69(1):48-53. PubMed ID: 10641443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
    Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S
    Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P-selectin can promote thrombus propagation independently of both von Willebrand factor and thrombospondin-1 in mice.
    Prakash P; Nayak MK; Chauhan AK
    J Thromb Haemost; 2017 Feb; 15(2):388-394. PubMed ID: 27943541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-collagen interaction: inhibition by ristocetin and enhancement by von Willebrand factor-platelet binding.
    LaDuca FM; Bettigole RE; Bell WR; Robson EB
    Blood; 1986 Oct; 68(4):927-37. PubMed ID: 3489493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Removal of the vicinal disulfide enhances the platelet-capturing function of von Willebrand factor.
    Tischer A; Moon-Tasson L; Auton M
    Blood; 2023 Mar; 141(12):1469-1473. PubMed ID: 36603190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha.
    Cauwenberghs N; Vanhoorelbeke K; Vauterin S; Westra DF; Romo G; Huizinga EG; Lopez JA; Berndt MC; Harsfalvi J; Deckmyn H
    Blood; 2001 Aug; 98(3):652-60. PubMed ID: 11468163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
    Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
    Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of the von Willebrand factor A1 domain to histone.
    Ward CM; Tetaz TJ; Andrews RK; Berndt MC
    Thromb Res; 1997 Jun; 86(6):469-77. PubMed ID: 9219327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
    Ward CM; Andrews RK; Smith AI; Berndt MC
    Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet physiology and thrombosis.
    Andrews RK; Berndt MC
    Thromb Res; 2004; 114(5-6):447-53. PubMed ID: 15507277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin.
    Chen J; Ling M; Fu X; López JA; Chung DW
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2625-30. PubMed ID: 22922961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex.
    Shen Y; Romo GM; Dong JF; Schade A; McIntire LV; Kenny D; Whisstock JC; Berndt MC; López JA; Andrews RK
    Blood; 2000 Feb; 95(3):903-10. PubMed ID: 10648402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.